Who
Gregory L. Verdine
Director
Company insider
Files Form 4 as: Director, Wave Life Sciences; Director, Enanta Pharmaceuticals.
In numbers
- Trades disclosed
- 32
- Buys
- 1
- Sells
- 6
- Bought
- $47K
- Sold
- $2.9M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 20 Mar 2013
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —10,700 at $0.00 | filing |
| 5 Oct 2026filed 7 Oct 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —64,000 at $0.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $157K12,020 at $13.09 | filing |
| 8 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $112K7,980 at $14.05 | filing |
| 22 Aug 2025filed 26 Aug 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $100K10,000 at $10.00 | filing |
| 11 Aug 2025filed 13 Aug 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,200 at $0.00 | filing |
| 11 Aug 2025filed 13 Aug 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —12,700 at $0.00 | filing |
| 13 Jun 2025filed 13 Jun 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $209K30,000 at $6.95 | filing |
| 7 Mar 2025filed 7 Mar 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —133,402 at $0.00 | filing |
| 7 Mar 2025filed 7 Mar 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $331K133,402 at $2.48 | filing |
| 5 Mar 2025filed 7 Mar 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —133,000 at $0.00 | filing |
| 5 Mar 2025filed 7 Mar 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $330K133,000 at $2.48 | filing |
| 12 Aug 2024filed 14 Aug 2024 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,230 at $0.00 | filing |
| 12 Aug 2024filed 14 Aug 2024 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —16,115 at $0.00 | filing |
| 7 Aug 2023filed 9 Aug 2023 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 27 Oct 2022filed 28 Oct 2022 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —163,467 at $0.00 | filing |
| 15 Aug 2022filed 17 Aug 2022 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 16 Aug 2021filed 18 Aug 2021 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,000 at $0.00 | filing |
| 18 Aug 2020filed 20 Aug 2020 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,500 at $0.00 | filing |
| 20 Nov 2019filed 22 Nov 2019 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $727K24,030 at $30.27 | filing |
News
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026WVE · manilatimes.net · 20 Oct 2026Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026WVE · manilatimes.net · 19 Oct 2026WAVE Life Sciences (NASDAQ:WVE) and Alumis (NASDAQ:ALMS) Head to Head ComparisonWVE · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Gregory L. Verdine; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.